Master Data

Registry
Register court Cottbus HRB 15855
Registered
11/24/2021
Industry
Research and experimental development on biotechnologyManufacture of basic pharmaceutical productsManufacture of irradiation, electromedical and electrotherapeutic equipment
Purpose
Die Entwicklung von immunstimulierenden Molekülen zur Behandlung von Krebserkrankungen und Infektionen.

History

No events found for this filter

Management

NameRole
Thomas Dr. Dümmler
since 5/15/2025
Procura
Angelika Sandra Leppert
since 11/24/2021
Managing Director
Managing Director

Beneficial Owners

Beneficial owner data is only accessible to registered users.

Shareholders

8 shareholders

GmbH structure

5 of 8 shown

Johanna Holdack
Berlin
€75,000
35.09%
Remiges BioPharma Fund II, LP
CYM
€43,750
20.47%
Germany
€34,375
16.08%
Eckenstein-Geigy-Stiftung
Switzerland
€30,938
14.47%
Germany
€18,750
8.77%

News & Media Coverage

Insolvency Notices

Current insolvency proceedings

Check if there are any insolvency proceedings for this company

Commercial Register Documents

Shareholder List
Current Print (Aktueller Abdruck)
Chronological Print (Chronologischer Abdruck)

Organizations at this Address

99 nearby organizations

List of companies and organizations located at or near this business address. Data includes company names, addresses, registration details, and industry classifications.
The information on this page is sourced from public sources, official registries, or provided by third-party providers. Fusionbase does not guarantee the accuracy, completeness, or timeliness of the data. If you have any questions or suggestions, feel free to contact us via the contact form.